Analysts Barclays initiate coverage of IBM (IBM) with overweight rating and $350 target price, citing quantum computing potential
Barclays has initiated coverage of IBM with an overweight rating, highlighting the company's significant investment in quantum computing, which could lead to substantial stock gains for investors.